28387-13-5

Basic information

• Product Name: Benzene, 4-nitro-1,2-bis(phenylmethoxy)-
• Synonyms: 3,4-dibenzyloxy-1-nitrobenzene;4-Nitro-brenzcatechin-dibenzylaether;3,4-Bis(phenylmethoxy)nitrobenzene;4-Nitro-1.2-dibenzyloxy-benzol;1,2-Bis-benzyloxy-4-nitro-benzol;3,4-bis-benzyloxy-nitrobenzene
• CAS NO: 28387-13-5
• Molecular Formula: C20H17NO4
• Molecular Weight: 335.359
• Mol File: 28387-13-5.mol
• Article Data: 7

Chemical Properties

• Melting Point: 97 °C
• Boiling Point: 512.1±40.0 °C(Predicted)
• Density: 1.238±0.06 g/cm3(Predicted)
• CAS DataBase Reference: Benzene, 4-nitro-1,2-bis(phenylmethoxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzene, 4-nitro-1,2-bis(phenylmethoxy)-(28387-13-5)
• EPA Substance Registry System: Benzene, 4-nitro-1,2-bis(phenylmethoxy)-(28387-13-5)

Safety Data

• Hazardous Substances Data: 28387-13-5(Hazardous Substances Data)

Upstream product

• 369-34-6 3,4-difluoronitrobenzene 
• 100-51-6 benzyl alcohol 
• 3316-09-4 1,2-dihydroxy-4-nitrobenzene 
• 100-39-0 benzyl bromide 
• 100-44-7 benzyl chloride 
• 10403-73-3 1,2-di(benzyloxy)benzene 
• 7697-37-2 nitric acid 
• 64-19-7 acetic acid 
• 2242-35-5 2-benzyloxy-5-nitrophenol 

Downstream Products

• 709-09-1 3,4-dimethoxynitrobenzene 
• 749791-90-0 1-(3,4-Bis-benzyloxy-phenyl)-2-methyl-isothiourea 
• 18002-45-4 acetic acid-(3,4-bis-benzyloxy-anilide) 
• 57005-09-1 (3,4-Bis-benzyloxy-phenyl)-thiourea 
• 36383-33-2 4-nitro-1,2-benzenediol diacetate 
• 18002-44-3 3,4-Bis(phenylmethoxy)benzeneamine 
• 3316-09-4 1,2-dihydroxy-4-nitrobenzene 
• 121969-19-5 2,3,8,9-tetrakis-benzyloxy-6H,12H-5,11-methano-dibenzo[b,f][1,5]diazocine 
• 103443-27-2 5,11-diacetyl-2,3,8,9-tetrakis-benzyloxy-5,6,11,12-tetrahydro-dibenzo[b,f][1,5]diazocine 

Relevant articles and documents

Synthesis and evaluation of azalamellarin N and its A-ring-modified analogues as non-covalent inhibitors of the EGFR T790M/L858R mutant

Azalamellarin N, a synthetic lactam congener of the marine natural product lamellarin N, and its A-ring-modified analogues were synthesized and evaluated as potent and non-covalent inhibitors of the drug-resistant epidermal growth factor receptor T790M/L8

C-MET MODULATORS AND METHODS OF USE

The present invention provides compounds for modulating protein kinase enzymatic activity for modulating cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. More specifically, the invention provides quinazolines and quinolines which inhibit, regulate and/or modulate kinase receptor, particularly c-Met, KDR, c-Kit, flt-3 and flt-4, signal transduction pathways related to the changes in cellular activities as mentioned above, compositions which contain these compounds, and methods of using them to treat kinase-dependent diseases and conditions. The present invention also provides methods for making compounds as mentioned above, and compositions which contain these compounds.

New non peptidic C5a receptor antagonists

A series of phenylguanidines which bind to the C5a receptor has been developed. The lead compound 1 (IC50 = 30 μM), discovered through random screening, has been modified to provide 32 (RPR121154) with submicromolar activity. This compound was